Of 2,115 patients with symptomatic aortic stenosis at high surgical risk receiving TAVR in the PARTNER ( Placement of Aortic Transcatheter Valves ) randomized trial or continued access registry , 690 had both severe LV hypertrophy ( left ventricular mass index [ LVMi ] 149 g/m ( 2 ) men , 122 g/m ( 2 ) women ) at baseline and an LVMi measurement at 30-day post-TAVR follow-up .